Sirtuins in hematological aging and malignancy.
Mendel Roth1, Zhiqiang Wang1, Wen Yong Chen1
1Department of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California 91010, USA.
Critical Reviews in Oncogenesis
|March 4, 2014
Summary
Sirtuins, particularly SIRT1, SIRT3, and SIRT6, show promise in combating hematological aging and related diseases. Enhancing sirtuin activity may improve hematopoietic stem cell function and offer new treatments for blood cancers.
Area of Science:
- Gerontology
- Hematology
- Molecular Biology
Background:
- Hematopoietic stem cell (HSC) aging leads to anemia, immune decline, and increased cancer risk.
- Sirtuins are key regulators of metabolism, genome stability, and cell survival, influencing aging and longevity.
- Dysfunctional HSCs are central to age-related hematological disorders.
Purpose of the Study:
- To provide an updated overview of sirtuins in aging research, focusing on their role in HSC aging and hematological malignancies.
- To explore how sirtuin activity impacts aging parameters and lifespan.
- To examine the influence of sirtuins on HSC signaling pathways.
Main Methods:
- Literature review of sirtuin functions in aging and hematopoiesis.
- Analysis of sirtuin involvement in age-dependent hematological malignancies.
- Examination of sirtuin effects on HSC signaling pathways.
Main Results:
- Increased activity of SIRT1, SIRT3, or SIRT6 may improve aging parameters and potentially extend lifespan in mice.
- SIRT1 is critical in chronic myelogenous leukemia, an age-related cancer.
- SIRT1 inhibition sensitizes leukemic stem cells to treatment and prevents resistance.
Conclusions:
- Sirtuins play a significant role in HSC aging and the development of hematological malignancies.
- Targeting sirtuins offers potential therapeutic strategies for age-related blood disorders.
- Further understanding of sirtuins can lead to novel treatments for hematological aging and cancers.
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
01:37Mitochondria
13.4K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.4K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
02:15Replicative Cell Senescence
3.5K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.5K
02:15Replicative Cell Senescence
3.0K
3.0K
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K